Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
1dOpinion
Opinion: A wider look at kratom and Connecticut. Synthetic derivatives and natural leaves differ
While not risk-free, natural leaf kratom offers an accessible option, and many users report that it helps them regain control ...
October 30th is the day when Eli Lilly will report its third-quarter results, including sales of its 'superstars' Zepbound ...
Preliminary efficacy data, combined with a tolerable safety profile, reinforce the potential of ZW191 in patients with ...
In September 2024, Sanofi entered an exclusive licensing agreement with Orano Med and RadioMedix to globally commercialize ...
Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 win in a rare bone cancer that currently has no approved ...
Early research suggests a brain test may predict whether antidepressants will cause sexual dysfunction. There has never been ...
TipRanks on MSN
AlphaTON, Cyncado recaps preclinical mesothelioma data
AlphaTON Capital (ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, issued a ...
About Alpha Cognition Inc. Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback